Administration of Elranatamab In the Real-World: Treatment Patterns, Healthcare Resource Utilization, Costs, Effectiveness, anD SafEty (ALTITUDE-2)

18/10/2024
27/01/2026
EU PAS number:
EUPAS1000000293
Study
Ongoing
Documents
Study protocol
Initial protocol
English (722.38 KB - PDF) View document
Updated protocol
English (1.14 MB - PDF) View document
Study results
Study report
Other information